Investing

Top 5 Canadian Mining Stocks This Week: Gold Stocks Surge as Price Strength Continues

The S&P/TSX Venture Composite Index (INDEXTSI:JX) gained 35.21 points this week to close at 580.43. Meanwhile, the S&P/TSX Composite Index (INDEXTSI:OSPTX) was up 787.22 points to finish the week at 23,568.65. Statistics Canada released August’s consumer price index (CPI) on Tuesday (September 17). The report indicated that inflation had increased 2 percent on an annualized...
Read more

SNX Returns 1,880g/t Silver, 31.2g/t Gold and 4.94% Copper at New High-Grade Silver, Gold, Copper and Antimony Prospects

Sierra Nevada Gold (ASX: SNX) is pleased to announce it has staked two additional projects prospective for high-grade silver-gold-copper near existing projects in Nevada, USA. The new projects are 10km west of SNX’s large-scale Blackhawk Porphyry and Epithermal Projects in Mineral County, SW Nevada (see figure 1). Highlights In conjunction with ongoing work at its...
Read more

​Tech 5: Microsoft Taps Three Mile Island to Power AI, Intel Shares New Strategy

All eyes were on interest rates this week as the US Federal Reserve’s two day meeting took place. Meanwhile, Bitcoin and Ether rallied later in the week, but analysts are uncertain about the sustainability of their gains. Elsewhere, Apple’s (NASDAQ:AAPL) iOS 18 update has already encountered problems, while Microsoft (NASDAQ:MSFT) and Intel (NASDAQ:INTC) announced major...
Read more

How to Invest in Silver (Updated 2024)

How to best invest in silver is a thought on many investors’ minds. Silver has long been an attractive vehicle not only for storing wealth, but for generating it too. Silver bugs rave about the growth opportunities to be had in a price rally. However, what goes up must come down, and the silver market...
Read more

FDA Fast Track Designation for Narmafotinib in Advanced Pancreatic Cancer

Amplia Therapeutics Limited (ASX: ATX), (“Amplia” or the “Company”), is pleased to announce that the United States Food and Drug Administration (FDA) has granted Fast Track Designation to Amplia’s Focal Adhesion Kinase inhibitor, narmafotinib, for the treatment of advanced pancreatic cancer. HIGHLIGHTS The US FDA has granted Fast Track Designation to Amplia’s lead drug narmafotinib...
Read more